Explore All Access
Check if your research matches the topics covered in Molecular Biomedicine?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Molecular Biomedicine : Impact Factor & More
eISSN: 2662-8651
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Molecular Biomedicine Key Metrics
Time to Publish 
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months7%
4 to 6 months74%
7 to 9 months14%
Above 9 months5%
Did you find this useful?
Molecular Biomedicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Springer |
| Language | English |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sichuan International Medical Exchange & Promotion Association |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 10 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Molecular Biomedicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Biomedicine
Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer.
- 15 Nov 2024
- Molecular biomedicine
XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.
- 13 Nov 2024
- Molecular biomedicine
Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma.
- 12 Nov 2024
- Molecular biomedicine
Prophylactic and therapeutic vaccine development: advancements and challenges.
- 11 Nov 2024
- Molecular biomedicine
Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer
- 8 Nov 2024
- Molecular Biomedicine
T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer
- 4 Nov 2024
- Molecular Biomedicine
Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer.
- 15 Nov 2024
- Molecular biomedicine
XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.
- 13 Nov 2024
- Molecular biomedicine
Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma.
- 12 Nov 2024
- Molecular biomedicine
Prophylactic and therapeutic vaccine development: advancements and challenges.
- 11 Nov 2024
- Molecular biomedicine
Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer
- 8 Nov 2024
- Molecular Biomedicine
T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer
- 4 Nov 2024
- Molecular Biomedicine
FAQs on Molecular Biomedicine
How many articles did Molecular Biomedicine publish last year? 
In 2023, Molecular Biomedicine publsihed 50 articles.
Who is the publisher of Molecular Biomedicine?
Springer is the publisher of Molecular Biomedicine.
